Brandinium

Trademark search for:

PROTHYA BIOSOLUTIONS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2021-10-18 — Application filed
  • 2022-04-21 — Sn assigned for sect 66a appl from ib
  • 2022-04-28 — Application filed
  • 2022-05-03 — Application filed
  • 2022-07-11 — Letter of protest evidence forwarded
  • 2022-07-25 — Assigned to examiner
  • 2022-07-27 — Final disposition recorded
  • 2022-07-28 — Office action issued
  • 2022-08-22 — Office action issued
  • 2022-08-23 — Final disposition recorded
  • 2022-08-24 — Office action issued
  • 2022-10-17 — Office action issued
  • 2022-10-17 — Office action issued
  • 2022-11-08 — Office action issued
  • 2023-04-17 — Office action issued
  • 2023-04-17 — Correspondence received in law office
  • 2023-04-18 — Teas/email correspondence entered
  • 2023-05-22 — Office action issued
  • 2023-05-22 — Office action issued
  • 2023-05-22 — Office action issued
  • 2023-08-10 — Teas request for reconsideration received
  • 2023-08-10 — Correspondence received in law office
  • 2023-08-10 — Teas/email correspondence entered
  • 2023-09-12 — Action req for recon denied no appeal filed counted not mailed
  • 2023-09-12 — Action for req for recon denied no appeal filed e-mailed
  • 2023-09-12 — Notification for req for recon denied no appeal filed
  • 2023-09-27 — Notification of possible opposition created, to be sent to ib
  • 2023-09-27 — Notification of possible opposition sent to ib
  • 2023-10-16 — Notification of possible opposition - processed by ib
  • 2023-10-18 — Teas request for reconsideration received
  • 2023-10-18 — Correspondence received in law office
  • 2023-10-18 — Teas/email correspondence entered
  • 2023-11-02 — Approved for pub - principal register
  • 2023-11-15 — Notification of notice of publication e-mailed
  • 2023-11-15 — Notification of possible opposition sent to ib
  • 2023-11-15 — Notice of start of opposition period created, to be sent to ib
  • 2023-12-03 — Notification processed by ib
  • 2023-12-05 — Published for opposition
  • 2023-12-05 — Official gazette publication confirmation e-mailed
  • 2023-12-21 — Extension of time to oppose received
  • 2024-06-04 — Office action issued
  • 2024-06-04 — Office action issued
  • 2024-06-10 — Opposition papers received at ttab
  • 2024-06-13 — Opposition instituted no. 999999
  • 2024-06-13 — Extension of time to oppose process - terminated
  • 2025-03-07 — Office action issued
  • 2025-03-11 — Opposition terminated no. 999999
  • 2025-03-11 — Opposition sustained no. 999999
  • 2025-03-11 — Application abandoned
  • 2025-03-11 — Application abandoned
  • 2025-03-11 — Final status recorded
  • 2025-05-09 — Office action issued

Owner Information

Sanquin Plasma Products B.V.
NL
Sanquin Plasma Products B.V.
NL

Correspondent

THOMAS J. MANGO CANTOR COLBURN LLP
20 CHURCH STREET, 22ND FLOOR
HARTFORD, CT 06103
UNITED STATES

Filing Details

Filing Date:
2021-10-18
Status Date:
2025-03-11
Category:
Pharmaceuticals
Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.